MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- POLY MEDICURE LIMITED (electronic equipments)
- Latest 8 Quarter Result
POLY MEDICURE Quarterly Results (POME)
Here are the latest quarterly results of POLY MEDICURE. For more details, see the POLY MEDICURE financial fact sheet and POLY MEDICURE share price and chart.
POLY MEDICURE Quarterly Results
| No. of Mths Qtr. Ending |
3
Jun-18 |
3
Sep-18 |
3
Dec-18 |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 1,314 | 1,468 | 1,487 | 1,599 | 1,524 | 1,632 | 1,714 | 1,592 | |
| Other income | Rs m | 33 | 41 | 37 | 47 | 42 | 50 | 40 | 54 | |
| Turnover | Rs m | 1,347 | 1,509 | 1,525 | 1,645 | 1,565 | 1,682 | 1,754 | 1,646 | |
| Expenses | Rs m | 1,001 | 1,122 | 1,176 | 1,243 | 1,156 | 1,227 | 1,266 | 1,212 | |
| Gross profit | Rs m | 313 | 345 | 311 | 356 | 368 | 405 | 448 | 380 | |
| Depreciation | Rs m | 86 | 91 | 94 | 93 | 97 | 100 | 105 | 91 | |
| Interest | Rs m | 38 | 64 | -9 | 19 | 31 | 15 | 52 | 79 | |
| Profit before tax | Rs m | 222 | 231 | 263 | 290 | 281 | 341 | 332 | 264 | |
| Tax | Rs m | 86 | 86 | 95 | 75 | 79 | 71 | 86 | 58 | |
| Profit after tax | Rs m | 136 | 145 | 168 | 215 | 202 | 270 | 246 | 206 | |
| Gross profit margin | % | 23.8 | 23.5 | 20.9 | 22.2 | 24.1 | 24.8 | 26.2 | 23.9 | |
| Effective tax rate | % | 38.7 | 37.4 | 36.0 | 25.9 | 28.2 | 20.8 | 26.0 | 21.9 | |
| Net profit margin | % | 10.4 | 9.9 | 11.3 | 13.4 | 13.2 | 16.6 | 14.3 | 12.9 | |
| Diluted EPS | Rs | 1.5 | 1.6 | 1.9 | 2.4 | 2.3 | 3.1 | 2.8 | 2.3 | |
| Diluted EPS (TTM) | Rs | 8.1 | 7.7 | 7.7 | 7.5 | 8.3 | 9.7 | 10.6 | 10.5 | |
 Subscriber Feature |
||||||||||
Interim results exclude extraordinary / exceptional items
Read: POLY MEDICURE 1QFY20 Result Performance Review
More Electronic Equipments Company Quarterly Results: CAPTAIN POLYPLAST APOLLO HOSPITALS SINTEX INDUSTRIES COMMEX TECHNOLOGY ADANI PORTS & SEZ
Compare POLY MEDICURE With: CAPTAIN POLYPLAST APOLLO HOSPITALS SINTEX INDUSTRIES COMMEX TECHNOLOGY ADANI PORTS & SEZ
Today's Market
Top 6 Factors Behind the Stock Market Rally, L&T Finance Holdings Rights Issue, and Buzzing Stocks Today(Pre-Open)
Indian share markets rallied nearly 2% yesterday, boosted by realty and finance stocks. Benchmark indices registered sharp gains yesterday after a massive selloff in the past two days.
Views on news
POLY MEDICURE Announces Quarterly Results (1QFY20); Net Profit Up 48.2% (Quarterly Result Update)
Aug 14, 2019 | Updated on Aug 14, 2019For the quarter ended June 2019, POLY MEDICURE has posted a net profit of Rs 202 m (up 48.2% YoY). Sales on the other hand came in at Rs 2 bn (up 16.0% YoY). Read on for a complete analysis of POLY MEDICURE's quarterly results.
POLY MEDICURE Announces Quarterly Results (4QFY19); Net Profit Down 6.8% (Quarterly Result Update)
May 15, 2019 | Updated on May 15, 2019For the quarter ended March 2019, POLY MEDICURE has posted a net profit of Rs 215 m (down 6.8% YoY). Sales on the other hand came in at Rs 2 bn (up 13.9% YoY). Read on for a complete analysis of POLY MEDICURE's quarterly results.
MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)
Mar 13, 2019Should you subscribe to the IPO of MSPC Limited?
More Views on NewsMost Popular
'Essential' Smallcap Stock Recommendations (Profit Hunter)
Jan 8, 2021The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
Is Nifty Forming a Top (Fast Profits Daily)
Jan 8, 2021The charts are telling the bulls to be cautious.
Why Gold Hit Lower Circuit (Fast Profits Daily)
Jan 11, 2021Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)
Jan 11, 2021Our ace stock picker is ready to capitalise on a big growth opportunity.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2021
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
POLY MEDICURE SHARE PRICE
Jan 19, 2021 (Close)
TRACK POLY MEDICURE
- Track your investment in POLY MEDICURE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON POLY MEDICURE
POLY MEDICURE 5-YR ANALYSIS
COMPARE POLY MEDICURE WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Warren Buffett - The Value Investor
- The Best Small-cap Stocks to Buy
- The Best Bluechip Stocks to Buy
- Your Ultimate Guide to Penny Stock Investing
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
FOLLOW
APP
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.